A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy

被引：0
|
作者：
Kenjiro Aogi
Hiroshi Sakai
Hirohisa Yoshizawa
Norikazu Masuda
Nobuyuki Katakami
Yasuhiro Yanagita
Kenichi Inoue
Masaru Kuranami
Mitsuhiro Mizutani
Noriyuki Masuda
机构：
[1] National Hospital Organization Shikoku Cancer Center,Department of Breast Oncology
[2] Saitama Cancer Center,Department of Thoracic Oncology
[3] Niigata University Medical and Dental Hospital,Bioscience Medical Research Center
[4] National Hospital Organization Osaka National Hospital,Department of Surgery
[5] Institute of Biomedical Research and Innovation,Division of Integrated Oncology
[6] Gunma Cancer Center,Department of Breast Oncology
[7] Saitama Cancer Center,Department of Breast Oncology
[8] Kitasato University School of Medicine,Department of Surgery
[9] Aichi Cancer Center Aichi Hospital,Department of Breast Surgery
[10] Kitasato University School of Medicine,Department of Respiratory Medicine
来源：
Supportive Care in Cancer | 2012年 / 20卷
关键词：
Palonosetron; 5-HT; receptor antagonist; Antiemetic; Chemotherapy-induced nausea and vomiting; Highly emetogenic chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1507 / 1514
页数：7
相关论文
共 50 条
  • [21] Phase II Study on EANI Combined with Hydrochloride Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting Following Highly Emetogenic Chemotherapy
    Xiao, Yang
    Liu, Jun
    Liu, Yang-Chen
    Huang, Xin-En
    Guo, Jian-Xong
    Wei, Wei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (09) : 3951 - 3954
  • [22] Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials
    Popovic, Marko
    Warr, David G.
    DeAngelis, Carlo
    Tsao, May
    Chan, Kelvin K. W.
    Poon, Michael
    Yip, Cheryl
    Pulenzas, Natalie
    Lam, Henry
    Zhang, Liying
    Chow, Edward
    SUPPORTIVE CARE IN CANCER, 2014, 22 (06) : 1685 - 1697
  • [23] Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (10) : 1019 - 1026
  • [24] Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy
    Schwartzberg, Lee S.
    McLaughlin, Trent
    Geller, Robert B.
    Gabrail, Nashat Y.
    Marks, Stanley M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (12) : 1161 - 1170
  • [25] Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)
    Karthaus, Meinolf
    Tibor, Csoszi
    Lorusso, Vito
    Singh-Arora, Rajender
    Filippov, Alexander
    Rizzi, Giada
    Borroni, Maria Elisa
    Rossi, Giorgia
    Grunberg, Steven M.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (10) : 2917 - 2923
  • [26] Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)
    Meinolf Karthaus
    Csőszi Tibor
    Vito Lorusso
    Rajender Singh-Arora
    Alexander Filippov
    Giada Rizzi
    Maria Elisa Borroni
    Giorgia Rossi
    Steven M. Grunberg
    Supportive Care in Cancer, 2015, 23 : 2917 - 2923
  • [27] Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients
    Sento, Shinya
    Kitamura, Naoya
    Yamamoto, Tetsuya
    Nakashiro, Koichi
    Hamakawa, Hiroyuki
    Ibaragi, Soichiro
    Sasaki, Akira
    Takamaru, Natsumi
    Miyamoto, Yoji
    Kodani, Isamu
    Ryoke, Kazuo
    Mishima, Katsuaki
    Ueyama, Yoshiya
    ANTICANCER RESEARCH, 2017, 37 (12) : 6977 - 6981
  • [28] Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
    Simhadri, Soumya
    Dayyala, Sowmya
    Musinipally, Anjani Devi
    Guram, Lavanya
    Madavi, Mamatha
    Kancha, Ramakrishna
    Puligundla, Krishna Chaitanya
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [29] A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy
    Tsutomu Takahashi
    Takahiro Okada
    Fumiyoshi Ikejiri
    Shunsuke Ito
    Yusuke Okada
    Fumimasa Takahashi
    Satoshi Kumanomido
    Yumi Jo
    Koji Adachi
    Chie Onishi
    Koshi Kawakami
    Takaaki Miyake
    Masaya Inoue
    Ritsuro Suzuki
    Junji Suzumiya
    International Journal of Clinical Oncology, 2018, 23 : 189 - 194
  • [30] A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy
    Takahashi, Tsutomu
    Okada, Takahiro
    Ikejiri, Fumiyoshi
    Ito, Shunsuke
    Okada, Yusuke
    Takahashi, Fumimasa
    Kumanomido, Satoshi
    Jo, Yumi
    Adachi, Koji
    Onishi, Chie
    Kawakami, Koshi
    Miyake, Takaaki
    Inoue, Masaya
    Suzuki, Ritsuro
    Suzumiya, Junji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 189 - 194
12345